PMID- 31031656
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20201001
IS  - 1664-0640 (Print)
IS  - 1664-0640 (Electronic)
IS  - 1664-0640 (Linking)
VI  - 10
DP  - 2019
TI  - Impact of Psychotherapy in Psychosis: A Retrospective Case Control Study.
PG  - 204
LID - 10.3389/fpsyt.2019.00204 [doi]
LID - 204
AB  - Background: The need for psychological therapies for psychosis has become 
      apparent since long-term antipsychotic drug treatment has a range of adverse side 
      effects, with moderate therapeutic effects at best. Aims: To investigate whether 
      the psychotherapeutic approach, dialogue therapy (DT) is associated with 
      improvements of symptoms and functioning beyond standard psychiatric treatment 
      (ST) in both schizophrenia and other psychosis. Methods: A retrospective 
      case-control design, comparing 54 patients with different psychoses who received 
      DT with 54 patients in a control group receiving ST was carried out. The groups 
      were matched on diagnosis, age, sex, and treatment start. Outcome measures were 
      Global assessment of functioning (GAF) scores, medications at follow up, and 
      hospital stays after completed outpatient treatment. Results: Mean time in 
      treatment from inclusion to follow-up was 3 years and 5 months. At follow-up, GAF 
      functioning (GAF-F) and GAF symptom (GAF-S) scores both were significantly higher 
      in the DT group than the ST group. Effect sizes (Cohen's d) were large; 1.8 for 
      GAF-S and 2.1 for GAF-F. At follow-up, the use of psychoactive drugs was 
      significantly reduced despite a shorter time in psychotherapy in the DT group 
      compared to the ST group. Days of hospitalizations after end of treatment in the 
      study period were significantly reduced in both groups compared to the period 
      before start of treatment. Conclusions: The findings from this exploratory study 
      are consistent with the possibility that dialogue therapy may lead to 
      improvements in symptoms and functioning compared to standard treatment in 
      psychosis.
FAU - Haram, Annbjorg
AU  - Haram A
AD  - Department of Psychiatry, More and Romsdal Hospital Trust, Alesund, Norway.
FAU - Fosse, Roar
AU  - Fosse R
AD  - Division of Mental Health and Addiction, Vestre Viken Hospital Trust, Drammen, 
      Norway.
FAU - Jonsbu, Egil
AU  - Jonsbu E
AD  - Department of Psychiatry, More and Romsdal Hospital Trust, Alesund, Norway.
AD  - Department of Mental Health, Faculty of Medicine and Health Sciences, Norwegian 
      University of Science and Technology, Trondheim, Norway.
FAU - Hole, Torstein
AU  - Hole T
AD  - Clinic of Medicine and Rehabilitation, More and Romsdal Hospital Trust, Alesund, 
      Norway.
AD  - Department of Circulation and Medical Imaging, Faculty of Medicine and Health 
      Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
LA  - eng
PT  - Journal Article
DEP - 20190411
PL  - Switzerland
TA  - Front Psychiatry
JT  - Frontiers in psychiatry
JID - 101545006
PMC - PMC6470395
OTO - NOTNLM
OT  - antipsychotic medication
OT  - dialogue therapy
OT  - global assessment of functioning
OT  - psychosis
OT  - psychotherapy
EDAT- 2019/04/30 06:00
MHDA- 2019/04/30 06:01
PMCR- 2019/04/11
CRDT- 2019/04/30 06:00
PHST- 2019/01/08 00:00 [received]
PHST- 2019/03/20 00:00 [accepted]
PHST- 2019/04/30 06:00 [entrez]
PHST- 2019/04/30 06:00 [pubmed]
PHST- 2019/04/30 06:01 [medline]
PHST- 2019/04/11 00:00 [pmc-release]
AID - 10.3389/fpsyt.2019.00204 [doi]
PST - epublish
SO  - Front Psychiatry. 2019 Apr 11;10:204. doi: 10.3389/fpsyt.2019.00204. eCollection 
      2019.